
Press Release
cultivate(MD) Capital Funds Announces HAPPE Spine’s Additional Patents for Hydroxyapatite Porous Polyetheretherketone Devices
Grand Rapids, Mich., October 5th, 2022— cultivate(MD) Capital Funds LP,

Grand Rapids, Mich., October 5th, 2022— cultivate(MD) Capital Funds LP,

Funds to Support Commercial Expansion and Post-Market Clinical Studies of

Grand Rapids, MI, July 25th, 2022 — Genesis Innovation Group’s

Grand Rapids, MI, June 06, 2022 — Genesis Innovation Group’s cultivate(MD) Capital Funds LP,

FDA decision supported by an interim clinical study report on

Recently, David Blue and Matt Ahearn presented on the latest